Novavax Inc (NVAX) stock news · rev $1.12B
Novavax Inc (NVAX) is a biotechnology company listed on US.
This NVAX news page leads with what Novavax Inc filed — not a scraped headline mill.
No cached 8-K sentence for NVAX yet. We will not pad this page with generic market recap.
Latest reported NVAX revenue for 2025-12-31 was $1.12B. Net income was $440.3M. Revenue was up 64.7% from 2024-12-31 to 2025-12-31. NVAX currently screens at market cap $1.09B.
EDGAR remains the official archive. Lician caches the exhibit so you can read what changed without a wire story.
Not investment advice. For the model open the NVAX stock page; for the tape open the quote page.
NVAX stock news FAQ
What are NVAX's latest revenue and net income?
Latest cached Novavax Inc (NVAX) revenue for Dec 31, 2025 was $1.12B. Net income was $440.3M. Statements: https://lician.com/financials/nvax
How did NVAX revenue change from the prior cached period?
Cached Novavax Inc (NVAX) revenue was up 64.7% from $682.2M (Dec 31, 2024) to $1.12B (Dec 31, 2025). Statements: https://lician.com/financials/nvax
What is NVAX's market cap?
Novavax Inc (NVAX) market cap is $1.09B on the latest cached fundamentals snapshot.
What kind of company is NVAX?
Novavax Inc (NVAX) is a biotechnology company listed on US.
Where is NVAX stock news listed?
Cached stock news for Novavax Inc (NVAX) is listed at https://lician.com/news/nvax. Filings: https://lician.com/sec/nvax
Not investment advice.